Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma
Philippe Moreau(Centre National de la Recherche Scientifique), Amrita Krishnan(City of Hope), Yunsi Olyslager(Janssen (Belgium)), Lixia Pei(Nanjing University of Chinese Medicine), Laura Rosiñol(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Surbhi Sidana(Palo Alto University), Jesús F. San Miguel(Clinica Universidad de Navarra), Ajay K. Nooka(Emory University), Danielle Trancucci(Centre Hospitalier Universitaire de Nantes), Lionel Karlin(Hôpital Lyon Sud), María‐Victoria Mateos(Hospital Clínico San Carlos), Niels W.C.J. van de Donk(Oncode Institute), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Alfred L. Garfall(University of Pennsylvania), Rian Van Rampelbergh(Janssen (Belgium)), Rachel Kobos(Centre Hospitalier Universitaire de Nantes), Ajai Chari(University of California, San Francisco), Albert Oriol(Institut Català d'Oncologia), Britta Besemer(Centre Hospitalier Universitaire de Nantes), Raluca Verona(Centre Hospitalier Universitaire de Nantes), Arnob Banerjee(Johnson & Johnson (United States)), Thomas G. Martin(University of California San Francisco Medical Center), Nizar J. Bahlis(Institute of Cancer Research), Suzette Girgis(Centre Hospitalier Universitaire de Nantes), Lotfi Benboubker, Tara Stephenson(Centre Hospitalier Universitaire de Nantes), Clarissa Uhlar(University of Pennsylvania), Rakesh Popat(University College London Hospitals NHS Foundation Trust), Mindy Jaffe(Centre Hospitalier Universitaire de Nantes), Jenna D. Goldberg(Centre Hospitalier Universitaire de Nantes), Hareth Nahi(Karolinska University Hospital), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center)
Cited by 40
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k